Immunomodulatory Agents and Factors in Poor Hematopoietic Stem Cell Mobilization: Current Strategies and Future Prospects. [PDF]
Alipourfard I +4 more
europepmc +1 more source
An open-label, randomized study comparing lipegfilgrastim with filgrastim in pediatric patients receiving chemotherapy for Ewing sarcoma or rhabdomyosarcoma. [PDF]
Belogurova MB +4 more
europepmc +1 more source
Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.
Riegler JS, Kesselheim AS, Rome BN.
europepmc +1 more source
Successful Use of Epcoritamab in Refractory Diffuse Large B-Cell Lymphoma with Central Nervous System Involvement: A Case Report. [PDF]
Uemura Y, Togitani K, Nakashima J.
europepmc +1 more source
G-CSF-induced Aortitis Mimicking TIPIC Syndrome. [PDF]
Nagashima T, Yabe H, Sekiguchi Y.
europepmc +1 more source
Unraveling the Crimson puzzle: Two case reports/case series of hemorrhagic cystitis after combination chemotherapy with docetaxel, carboplatin, trastuzumab and pertuzumab in breast cancer. [PDF]
Ramirez JC +5 more
europepmc +1 more source
Differential impact of pegfilgrastim, a recombinant human granulocyte colony stimulating factor, on the neutrophil count of male and female deer mice (Peromyscus maniculatus bairdii). [PDF]
Strydom JP +3 more
europepmc +1 more source
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study. [PDF]
Kumanishi R +14 more
europepmc +1 more source
Demonstration of physicochemical and functional similarity between Stimufend (pegfilgrastim-fpgk) and Neulasta (pegfilgrastim): A comparative analytical assessment. [PDF]
Sykes A +3 more
europepmc +1 more source

